Toggle Nav
Close
  • Menu
  • Setting

JDTic

Catalog No.
A3517
Opioid antagonist
Grouped product items
SizePriceStock Qty
5mg
$237.00
Ship with 10-15 days
10mg
$373.00
Ship with 10-15 days
50mg
$1,437.00
Ship with 10-15 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Ki = 0.3 nM

JDTic is a selective opioid Kappa receptor antagonist.

At least three opioid receptor subtypes, μ, δ, and κ, are responsible for the modulation of a diverse array of biological events from nociception to immune regulation. The baisi of studying this complex receptor system is for the identification of both agonists and antagonists with high degree of receptor subtype selectivity.

In vitro: JDTic demonstrated high affinity for the κ receptor in the binding assay and highly potent and selective κ antagonism in the [35S]GTP-γ-S assay. JDTic showed a 16-fold improvement in its κ receptor Ki value in the functional assay relative to the binding assay. In the [35S]GTP-γ-S functional assay, JDTic demonstrated a 3.4-fold increase in κ antagonist potency relative to the functional assay utilizing guinea pig membranes [1].

In vivo: JDTic was found to be able to dose-dependently block acute nicotineinduced antinociception in the tail-flick but not the hotplate test and did not attenuate morphine's antinociceptive effect significantly in either test. Moreover, JDTic failed to block the expression of nicotine reward as measured by the conditioned place preference model. In contrast, JDTic attenuated the expression of both physical and affective nicotine withdrawal signs in mice[2].

Clinical trial: N/A

References:
[1] Thomas JB,Atkinson RN,Rothman RB,Fix SE,Mascarella SW,Vinson NA,Xu H,Dersch CM,Lu Y,Cantrell BE,Zimmerman DM,Carroll FI.  Identification of the first trans-(3R,4R)- dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid kappa receptor antagonist activity. J Med Chem.2001 Aug 16;44(17):2687-90.
[2] Jackson KJ,Carroll FI,Negus SS,Damaj MI.  Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse. Psychopharmacology (Berl).2010 Jun;210(2):285-94.

Product Citation

Chemical Properties

StorageStore at -20°C
M.Wt465.63
Cas No.361444-66-8
FormulaC28H39N3O3
SolubilitySoluble in DMSO
Chemical Name7-hydroxy-N-(1-(4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)-3-methylbutan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide
SDFDownload SDF
Canonical SMILESCC1CN(CC(NC(C2CC3=C(C=C(O)C=C3)CN2)=O)C(C)C)CCC1(C4=CC(O)=CC=C4)C
Shipping ConditionSmall Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips We do not recommend long-term storage for the solution, please use it up soon.

Quality Control

Quality Control & MSDS

View current batch:

Chemical structure

JDTic